Nanoparticles therapeutic strategies for the treatment human diseases The above-mentioned small molecule ferroptosis regulators have demonstrated potential in preclinical practice for treating various diseases
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Future work should further explore concussion sub-groups not identified in the current study to better characterize different injury trajectories and the impact of symptoms
Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Shaiova L, et al
But researchers didn't stop there
It slows digestion and reduces how quickly glucose enters the bloodstream